THOMAS CUTILLO: Open Payments
NPI 1225201353 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 7 payments from 5 companies in 2025. Trend: 2023 $264 · 2024 $297 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $124 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| PFIZER INC. | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $14 |
Products named: CAPLYTA, PREVNAR 20, JARDIANCE, Auvelity, Symbravo.
Industry payments across CA — which companies pay providers there.
